BIOHLDG 0179 INFORMATION OVERVIEW 1
Information Overview 1:
该集团进入印尼和中国市场多年但没有什么成长。
该集团在印尼的一个名为廖内省的一个地方与一家印尼伙伴联号设立一间工厂，并在2016年初已经完成，但到现在却没得到印尼政府的一点回应。
该集团已经呈交功能食品和保健品资料给印尼政府，功能食品已得到印尼政府同意到保健品却还没得到印尼政府同意。
该集团与中国的金睿财富控股集团签署一份备忘录并定下三年到十年里开设1000家医馆。
该集团在并购同行业的加盟店事件并不顺利主要是卖家不愿卖和卖价高因素。
该集团在雪州的工厂使用率是80%。
该集团在登嘉楼的工厂正在建设，预计2019年能正式开始营运。
该集团在登嘉楼建设工厂主要是该厂房与当地种草药的地方相近可节省一些费用和时间。
该集团预计位于柔佛的一块300英亩的草药园将会在今年尾开始种植，并预计将在明年开始贡献盈利。
该集团预计登嘉楼和柔佛的草药园在明年能生产大约1000公吨的草药。
Disclaimer:
The information contained in this research is based on data obtained from sources believed to be reliable. However, the data and/or sources have not been independently verified and as such, no representation, express or implied, is made as to the accuracy, adequacy, completeness or reliability of the info or opinions in the research.
Accordingly, neither 以牛攻熊 nor any of its related companies and associates nor person connected to it accept any liability whatsoever for any direct, indirect or consequential losses (including loss of profits) or damages that may arise from the use or reliance on the info or opinions in this publication. Any information, opinions or recommendations contained herein are subject to change at any time without prior notice. 以牛攻熊 has no obligation to update its opinion or the information in this research.
Investors are advised to make their own independent evaluation of the info contained in this research and seek independent financial, legal or other advice regarding the appropriateness of investing in any securities or the investment strategies discussed or recommended in this research. Nothing in this research constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise represent a personal recommendation to you.
This research is being supplied to you on a strictly confidential basis solely for your information and is made strictly on the basis that it will remain confidential. All materials presented in this research, unless specifically indicated otherwise, is under copyright to 以牛攻熊. This research and its contents may not be reproduced, stored in a retrieval system, redistributed, transmitted or passed on, directly or indirectly, to any person or published in whole or in part, or altered in any way, for any purpose.
This research may provide the addresses of, or contain hyperlinks to, websites. 以牛攻熊 takes no responsibility for the content contained therein. Such addresses or hyperlinks (including addresses or hyperlinks to 以牛攻熊 own site material) are provided solely for your convenience. The information and the content of the linked site do not in any way form part of this research. Accessing such website or following such link through the research or 以牛攻熊 site shall be at your own risk.
该集团进入印尼和中国市场多年但没有什么成长。
该集团在印尼的一个名为廖内省的一个地方与一家印尼伙伴联号设立一间工厂，并在2016年初已经完成，但到现在却没得到印尼政府的一点回应。
该集团已经呈交功能食品和保健品资料给印尼政府，功能食品已得到印尼政府同意到保健品却还没得到印尼政府同意。
该集团与中国的金睿财富控股集团签署一份备忘录并定下三年到十年里开设1000家医馆。
该集团在并购同行业的加盟店事件并不顺利主要是卖家不愿卖和卖价高因素。
该集团在雪州的工厂使用率是80%。
该集团在登嘉楼的工厂正在建设，预计2019年能正式开始营运。
该集团在登嘉楼建设工厂主要是该厂房与当地种草药的地方相近可节省一些费用和时间。
该集团预计位于柔佛的一块300英亩的草药园将会在今年尾开始种植，并预计将在明年开始贡献盈利。
该集团预计登嘉楼和柔佛的草药园在明年能生产大约1000公吨的草药。
Disclaimer:
The information contained in this research is based on data obtained from sources believed to be reliable. However, the data and/or sources have not been independently verified and as such, no representation, express or implied, is made as to the accuracy, adequacy, completeness or reliability of the info or opinions in the research.
Accordingly, neither 以牛攻熊 nor any of its related companies and associates nor person connected to it accept any liability whatsoever for any direct, indirect or consequential losses (including loss of profits) or damages that may arise from the use or reliance on the info or opinions in this publication. Any information, opinions or recommendations contained herein are subject to change at any time without prior notice. 以牛攻熊 has no obligation to update its opinion or the information in this research.
Investors are advised to make their own independent evaluation of the info contained in this research and seek independent financial, legal or other advice regarding the appropriateness of investing in any securities or the investment strategies discussed or recommended in this research. Nothing in this research constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise represent a personal recommendation to you.
This research is being supplied to you on a strictly confidential basis solely for your information and is made strictly on the basis that it will remain confidential. All materials presented in this research, unless specifically indicated otherwise, is under copyright to 以牛攻熊. This research and its contents may not be reproduced, stored in a retrieval system, redistributed, transmitted or passed on, directly or indirectly, to any person or published in whole or in part, or altered in any way, for any purpose.
This research may provide the addresses of, or contain hyperlinks to, websites. 以牛攻熊 takes no responsibility for the content contained therein. Such addresses or hyperlinks (including addresses or hyperlinks to 以牛攻熊 own site material) are provided solely for your convenience. The information and the content of the linked site do not in any way form part of this research. Accessing such website or following such link through the research or 以牛攻熊 site shall be at your own risk.
Comments
Post a Comment